Characteristics of Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Monoclonal Antibody New Users and Changes in Ldl-c Using Real-world Data: a U.s. Perspective
Year: 2023
Type: article
Institution: Amgen (United States)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4323035232
